Calm woman in soft natural light reflecting everyday female cycle and ovarian wellness with MyoBalan

Why 40:1? The Science of MyoBalan's Myo-Inositol to D-Chiro-Inositol Ratio

TL;DR:

  • Inositol comes in two forms that matter for the female cycle: myo-inositol (MI) and D-chiro-inositol (DCI). They are not interchangeable, and the ovary needs far more of the first than the second.
  • Healthy blood carries these two forms at roughly a 40-to-1 ratio, and research found that reproducing this 40:1 ratio supported ovulation better than DCI-heavy blends, an outcome sometimes called the D-chiro-inositol paradox.
  • MyoBalan is built to match that physiological 40:1 ratio rather than loading up on D-chiro-inositol, so the formula reflects how the ovary actually uses inositol.

Most inositol supplements compete on milligrams, but the number that matters most for the female cycle is not the total dose, it is the ratio between two closely related molecules. MyoBalan is built around a 40:1 ratio of myo-inositol to D-chiro-inositol because that is the proportion the body keeps in healthy blood, and because more D-chiro-inositol is not better.

Calm woman in soft natural light reflecting everyday female cycle wellness and hormonal wellness support

Table of Contents

Key Takeaways

Element What it does Why it matters in MyoBalan
Myo-inositol (MI) Acts as a second messenger for FSH signalling in the ovary's granulosa cells Supports the follicular environment and oocyte quality, so it is the dominant form
D-chiro-inositol (DCI) Involved in insulin-mediated processes; the ovary needs only a very small amount Useful in tiny quantities, but excess can work against the ovary
The 40:1 ratio Mirrors the proportion of MI to DCI found in healthy blood plasma Reproducing physiology rather than guessing at an arbitrary blend
DCI paradox More D-chiro-inositol can reduce, not improve, oocyte quality Explains why MyoBalan deliberately limits DCI
Cycle support design Pairs the right forms in the right proportion Supports menstrual cycle regularity and ovarian function as part of a daily routine

Two Inositols, Two Different Jobs

Inositol is a sugar-like molecule the body uses to relay hormonal signals inside cells. It exists in several stereoisomers, but two of them dominate the conversation around the female cycle: myo-inositol and D-chiro-inositol. The body makes D-chiro-inositol from myo-inositol through an insulin-dependent enzyme called an epimerase, and crucially, each tissue maintains its own characteristic ratio of the two depending on what that tissue needs. A broad review of how these molecules behave across reproductive tissues, set out in work on inositol as a putative integrative treatment for the female cycle (PubMed), makes the point that the two isomers are specialists rather than substitutes.

That single fact reframes the whole category. A supplement is not simply delivering "inositol"; it is delivering a specific mixture of two molecules that the ovary treats very differently. Get the proportion wrong and you can deliver plenty of total inositol while still missing what the ovary actually uses.

Myo-Inositol: The Ovary's Second Messenger

Inside the ovary, myo-inositol is the form that carries the signal from follicle-stimulating hormone (FSH) into the granulosa cells that surround and nourish a developing egg. When FSH binds its receptor, myo-inositol-based messengers help translate that hormonal instruction into the cellular activity that supports a healthy follicle. This is why myo-inositol availability is linked to the quality of the follicular environment, and why systematic reviews of myo-inositol in women with polycystic ovary syndrome (PubMed) have examined its role in supporting ovarian function and more regular cycles.

Because myo-inositol is doing the heavy lifting at the level of the egg and its surrounding cells, it makes sense that the ovary keeps myo-inositol as the overwhelmingly dominant form. The supporting role of D-chiro-inositol is real but small, and that asymmetry is the heart of the ratio story.

Scientific illustration of myo-inositol acting as an FSH second messenger inside an ovarian follicle and its granulosa cells

The D-Chiro-Inositol Paradox

For a long time, D-chiro-inositol was treated as the more "active" molecule, so some formulas loaded up on it. Research then revealed a counterintuitive result: while a small amount of D-chiro-inositol supports insulin-related signalling, too much of it in the ovary is associated with poorer oocyte quality. The question was framed directly in the influential commentary asking whether the ovary actually needs D-chiro-inositol (PubMed), and follow-up work on how D-chiro-inositol modulates gonadotrophin-induced enzymes in granulosa cells (PubMed) helped explain the mechanism behind it.

This is the so-called D-chiro-inositol paradox: the isomer that looks helpful for insulin can become counterproductive for the egg when its concentration in the ovary climbs too high. The practical lesson is that a thoughtful cycle-support formula should keep D-chiro-inositol deliberately low, not maximise it. That principle is reinforced by calls for inositol supplementation to be science-based rather than arbitrary (PubMed).

Why 40:1 Specifically

If less D-chiro-inositol is better, why not zero? Because the body does maintain a small, stable amount, and the proportion it keeps in healthy plasma is approximately 40 parts myo-inositol to 1 part D-chiro-inositol. Rather than inventing a ratio, the most physiological approach is to copy the one the body already trusts. A direct comparison of different ratios reported that the 40:1 myo-inositol to D-chiro-inositol ratio supported ovulation more effectively than other proportions (PubMed), which is why 40:1 has become a reference point in the field.

The logic is conservative in the best sense. Instead of betting on a novel blend, a 40:1 formula reproduces the proportion measured in healthy blood, supplies myo-inositol as the dominant working form, and includes just enough D-chiro-inositol to reflect normal physiology without tipping into the paradox.

How MyoBalan Applies the Ratio

MyoBalan is formulated around exactly this principle. It pairs 900 mg of myo-inositol with a small, matched amount of D-chiro-inositol to hold the 40:1 proportion, so the dominant molecule is the one the ovary uses as its FSH second messenger. The dose is fully declared rather than hidden inside a proprietary blend, which means you can see the ratio for yourself instead of trusting a marketing claim.

The aim is everyday consistency. Inositol is not a quick fix; it is a daily building block, and the studies that examined cycle regularity and ovarian function did so over sustained supplementation. MyoBalan is designed to make that daily 40:1 intake simple, so the routine itself becomes the active ingredient. As always, it is a food supplement that supports general wellness rather than a treatment for any medical condition.

Infographic comparing a balanced 40 to 1 myo-inositol to D-chiro-inositol ratio against an imbalanced ratio for ovarian wellness

MyoBalan vs a High-DCI Blend

Feature BioEssentials MyoBalan Generic high-DCI blend
Uses the physiological 40:1 MI:DCI ratio ✓ ✗
Keeps D-chiro-inositol deliberately low ✓ ✗
Myo-inositol as the dominant FSH second messenger ✓ ✗
Fully declared doses, no proprietary blend ✓ ✗
Designed for sustained daily cycle support ✓ ✓
Vegan, Non-GMO, EU-made, Eurofins tested ✓ ✗

Discover MyoBalan with BioEssentials

If you want a cycle-support formula designed around how the ovary actually uses inositol rather than around the biggest D-chiro-inositol number, explore MyoBalan by BioEssentials. It holds myo-inositol and D-chiro-inositol at the physiological 40:1 ratio in fully declared doses to support your menstrual cycle and ovarian wellness day to day.

Frequently Asked Questions

What is MyoBalan designed to do?

MyoBalan is a food supplement formulated to support the menstrual cycle and ovarian wellness. It supplies myo-inositol and D-chiro-inositol in a 40:1 ratio to reflect how the ovary uses these molecules, rather than acting as a medicine.

Why does the ratio matter more than the total dose?

Because myo-inositol and D-chiro-inositol do different jobs, and the ovary needs far more of the first. A formula can contain plenty of total inositol yet still be skewed toward D-chiro-inositol, which research links to poorer oocyte quality when it is too high.

What is the D-chiro-inositol paradox?

It describes the finding that, although D-chiro-inositol supports insulin-related signalling, an excess of it inside the ovary is associated with reduced egg quality. This is why a thoughtful formula keeps D-chiro-inositol low rather than maximising it.

Is MyoBalan a medicine?

No. MyoBalan is a food supplement intended to support general wellness. It is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for medical care.

Who is MyoBalan suitable for?

It is designed for adult women who want daily support for cycle regularity and ovarian wellness. If you are pregnant, breastfeeding, taking medication or managing a health condition such as PCOS, consult a healthcare professional first.

Scientific References

These statements have not been evaluated by the Food and Drug Administration. BioEssentials products are food supplements intended to support general wellness and daily nutritional needs. They are not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare professional before starting any new supplement if you are pregnant, breastfeeding, taking medication, or managing a health condition.

Back to News

Featured collection

View all